2025年12月28日结束对Vivani医疗股份的为期61天的监管,允许执行官出售受限股票。 A 61-day lock-up on Vivani Medical shares ends Dec. 28, 2025, allowing executives to sell restricted stock.

Vivani Medical Inc.的禁闭协议于2025年12月28日到期,结束了2025年10月28日开始的61天限制。 A lock-up agreement for Vivani Medical, Inc. expires on December 28, 2025, ending a 61-day restriction that began October 28, 2025. 该协定适用于约6 320万共同股份和某些股票选择权,禁止董事和高管出售、转让或质押其股份或可兑换证券,但有少数例外。 The agreement, applicable to approximately 63.2 million common shares and certain stock options, prohibits directors and executives from selling, transferring, or pledging their shares or convertible securities, with limited exceptions. 这项措施是按公开报价后的标准采取的,旨在防止市场洪涝,并在初始贸易期内稳定股票价格。 This measure, standard after public offerings, aims to prevent market flooding and stabilize stock prices during the initial trading period.